NASDAQ: AVTXAvalo Therapeutics Inc Stock Ownership - Who owns Avalo Therapeutics?
Insider buying vs selling
Have Avalo Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when AVTX insiders and whales buy or sell their stock.
AVTX Shareholders
What type of owners hold Avalo Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 4,991.17% | 51,615,185 | $504.18M | Insider |
| Robert Moscato Jr. | 865.72% | 8,952,643 | $87.45M | Insider |
| Randal Jones | 615.00% | 6,359,900 | $62.12M | Insider |
| Steven Boyd | 226.83% | 2,345,714 | $22.91M | Insider |
| Patrick J. Crutcher | 158.08% | 1,634,771 | $15.97M | Insider |
| Apple Tree Partners Iv LP | 57.58% | 595,436 | $5.82M | Insider |
| Mpm Bioventures V LP | 57.58% | 595,436 | $5.82M | Insider |
| M. James Barrett | 57.46% | 594,245 | $5.80M | Insider |
| Patrick J. Kerins | 57.46% | 594,245 | $5.80M | Insider |
| New Enterprise Associates 14 LP | 57.46% | 594,245 | $5.80M | Insider |
AVTX vs Biotech Stocks
Avalo Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.